Articles tagged with Liver
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found that high-fat diets depleted NKT cells, a type of immune cell that regulates cytokine production. This depletion led to increased pro-inflammatory cytokines, promoting chronic liver disease.
Researchers identified alpha-smooth muscle actin (alpha-SMA) as a reliable marker for predicting fibrosis development after liver transplant. Studies showed that HSC activation was associated with advanced fibrosis, suggesting a potential biomarker for early intervention and treatment.
Portal hypertension affects blood flow into the liver, causing high pressure that can lead to bleeding and death. Researchers identified a cellular mechanism leading to reduced nitric oxide production, which can be restored by reducing GRK2 protein production.
The pediatric acute liver study, directed from Children's, will investigate the causes and treatment of acute liver failure in children. The three aspects of the study include developing a registry, therapeutic clinical trials, and basic research into genetic causes of the condition.
Research shows that liver production of CRP is associated with atherosclerotic lesions, contradicting previous suggestions that CRP was merely a risk factor. Liver-derived CRP levels positively correlate with plaque size in rabbit models of atherosclerosis.
Mayo Clinic's new treatment protocol combining radiation therapy, chemotherapy, and liver transplantation has significantly improved the five-year survival rate for patients with bile duct cancer to 82%. The treatment enables surgeons to remove the entire liver and obtain better tumor clearance.
Researchers at the Salk Institute have identified a new target for diabetes treatment: the protein TORC2. TORC2 regulates glucose production in liver cells and its activation can improve insulin sensitivity. The discovery holds promise for developing more effective diabetes medications.
A diet high in soy protein prevents the accumulation of triglycerides and cholesterol in the liver despite obesity and hyperinsulinemia. This is achieved through reduced expression of genes involved in lipid production and increased breakdown of fatty acids.
A recent study published by the American Gastroenterological Association found that nearly 80% of Asian patients with chronic HCV developed cirrhosis after 60 years of infection. The study's results confirm that fibrosis progression is the same across ethnic groups, leading to cirrhosis and liver disease at a similar rate in everyone.
A new protein called ABIN-1 has been discovered that can prevent the death of liver cells in people with hepatitis. Researchers have shown that an extra dose of ABIN-1 provides a double protective effect against inflammation and cell death, offering new hope for treating liver disorders.
Research suggests that high blood lactate levels can accurately predict a poor outcome in patients with fulminant hepatic failure (FHF). The study examined the relationship between serum phosphate and lactate levels in FHF patients, finding that lactate levels were significantly higher in those who died or underwent a transplant.
A study published in Cell reveals that PGC-1 alpha, a metabolic regulator, plays a crucial role in the development of porphyria symptoms. Fasting and certain drugs can trigger attacks, which can be treated with high-carbohydrate diets and glucose feedings.
A study of 1,193 patients found only 94 received the HAV vaccine, highlighting a significant gap in vaccination rates. Patients with chronic HCV were at risk for severe liver disease and death if infected with HAV, emphasizing the need for increased awareness and vaccination efforts.
A new BCG vaccine strain protects against tuberculosis with high efficacy, while a novel TWEAK pathway induces liver cell proliferation in response to injury. These findings may lead to specific therapies for liver diseases and improved TB protection.
Researchers at the University of Minnesota have found that increasing fructose-2,6-bisphosphate in the liver can decrease blood sugar levels in mice. This process may also lead to weight loss by reducing food intake and increasing energy expenditure. The study's findings could potentially lead to new treatments for diabetes and obesity.
Researchers have solved the mystery of the Shoenheimer effect, a 72-year-old cholesterol feedback mechanism. The study reveals that Insig proteins are essential components of this response and play a crucial role in regulating cholesterol synthesis.
A new contrast agent enables quicker and more thorough MRI screenings for potential living liver donors. The study found that this agent can image the liver, bile duct, and vessels simultaneously, reducing the need for separate examinations.
Researchers found that alendronate, combined with calcium and vitamin D, significantly prevented further bone loss in liver transplant patients for four months after the procedure. After three years, patients with osteopenia or osteoporosis showed improved BMD despite not reaching normal levels.
New study reveals that acute insulin pulses limit fat synthesis in the liver by activating a key molecule called CEACAM1. Regular periods of fasting between meals help maintain a healthy liver by allowing insulin levels to fluctuate.
A recent study has identified mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 (mtGPAT1) as a trigger for insulin resistance in the liver. The researchers found that mice lacking this enzyme were protected from fatty liver and liver insulin resistance, suggesting mtGPAT1 as a potential therapeutic target.
A study analyzing reports of suspected drug-induced liver injury found that AST and bilirubin levels are key predictors of death or liver transplant in patients with severe drug-induced liver disease. Patients with hepatocellular liver damage had a higher mortality rate, highlighting the importance of monitoring these biomarkers.
A recent study published in the American Journal of Roentgenology found that contrast-enhanced MRI is more accurate than FDG-PET in detecting liver tumors, especially for smaller lesions. The study analyzed 79 liver tumors and showed an accuracy rate of 75.5% for MRI versus 64.1% for PET.
Researchers found that asymptomatic autoimmune hepatitis patients had lower liver enzyme and IgG antibody levels, but did not differ from symptomatic patients in terms of inflammation. Despite treatment recommendations, most asymptomatic patients do well without immunosuppressive therapy as long as they remain asymptomatic.
A new method of controlling blood levels of calcineurin inhibitors (CNIs) improves the success of liver transplants by reducing variation and toxicity. The four-step process increases CNI levels within target ranges from 50% to 80% in patients.
A phase I study has shown early promise for a cancer-killing virus targeting colorectal cancer. The virus, NV1020, selectively kills cancer cells while sparing normal tissue, leading to improved CEA reductions and median survival times of up to 23 months.
A study published in Hepatology found that severe sleep apnea is a risk factor for liver damage, independent of body mass index. Patients with severe sleep apnea had higher levels of insulin resistance and fatty liver disease, suggesting a link between obstructive sleep apnea and the development of nonalcoholic steatohepatitis.
CellCept shows benefits for liver transplant patients, similar to those seen in kidney transplant recipients, with reduced risk of acute rejection and improved kidney function. The treatment also promotes safe steroid-free regimens and reduces liver fibrosis.
A seven-year review of liver transplant recipients who received HBV positive and HCV positive organs found patient and graft survival rates comparable to those receiving livers from negative donors. The use of these organs increases the number available for transplantation while maintaining long-term results.
A recent study found a significant percentage of patients who received a liver transplant due to alcoholic liver disease also used tobacco post-transplant. The majority of smokers resumed their habit quickly and showed increased consumption over time, highlighting the need for more stringent monitoring and intervention.
A steroid-free regimen with CellCept was found to be comparable to standard therapy in liver transplantation, without increasing the risk of hepatitis C recurrence. The study involved 312 adult patients and showed that the CellCept-based regimen demonstrated comparable efficacy and safety profiles.
Researchers have made a groundbreaking discovery by directly observing the liver invasion of malarial parasites using intravital microscopy. The study reveals a critical stage in the parasite's life cycle, where sporozoites traverse Kupffer cells to wreak havoc on liver tissue.
Researchers have found promising results from an early clinical trial of a novel treatment for uveal melanoma that has spread to the liver. The two-pronged treatment cuts off oxygen supply to tumors and stimulates the immune system, leading to tumor shrinkage and prolonged survival in patients.
Researchers found grapefruit seed extract accelerates ulcer healing by reducing gastric acid secretion and promoting blood flow at the ulcer site. The study suggests that grapefruit can be a beneficial addition to the diet for those with ulcers.
Researchers found that ablation therapy extended median survival to 33 months compared to 20 months for chemotherapy-only treatment. The study also showed improved disease recurrence rates and overall 3-year survival rate of 51%.
Children under five are most likely to die waiting for a liver transplant due to organ shortage. Living donor liver transplantation offers better graft and patient survival rates for pediatric patients.
Researchers found that increased LXR expression in the liver improves cholesterol and triglyceride levels on high-fat diets, but loses effect with experimental drugs. The study suggests that targeting natural ligands may be more effective in treating metabolic diseases.
A new study reveals that mice with an excess of liver X receptor (LXRa) are protected from high-fat diet-induced cholesterol and blood vessel plaques. The findings suggest that natural variation in LXRa levels can influence susceptibility to heart disease, depending on diet.
A new study published in Cell Metabolism found that normal metabolism requires so-called "new" fat to maintain glucose, lipid, and cholesterol homeostasis. The researchers discovered that old fat stores alone failed to set critical metabolic pathways in motion, leading to a marked decline in gene activity.
Genetically engineered mice with a missing enzyme in their livers developed fatty liver disease when placed on a zero-fat diet. The study found that consuming new fat, which is produced in the liver or consumed in food, helps regulate fat burning and prevents liver damage.
A recent study led by Elizabeth Parks from the University of Minnesota has made a groundbreaking discovery about the origin of fatty liver disease. The research found that excess dietary fat can lead to liver toxicity, causing it to malfunction in its role as the body's central storage and distribution center for fat.
Accumulated liver lipids come from serum fatty acids, newly made fatty acids within the liver, and dietary fatty acids. Insulin-sensitizing agents may help reduce oxidative stress and treat NAFLD.
Researchers found that liver cells express CB1 receptors, which activate a signaling pathway increasing fatty acid synthesis. This activation is similar to brain and may be a target for metabolic regulation and appetite control.
New research reveals that accumulated liver lipids originate from serum fatty acids, newly produced fatty acids within the liver, and dietary fatty acids. The study also highlights the potential role of endocannabinoids in regulating liver metabolism and appetite control. Additionally, a companion paper explores the relationship betwee...
A study of Southern Italian residents found that over 12% had abnormal liver values, with a significant correlation between age, gender, and excessive alcohol consumption. Nonalcoholic fatty liver disease emerged as an important cause of altered liver tests in the region.
Research finds that high cyclosporine levels are associated with increased risk of hepatocellular carcinoma (HCC) recurrence after liver transplantation. The study suggests tailoring immunosuppressive schedules to individual patients based on their tumor biology, and recommends minimizing exposure to cyclosporine to prevent recurrence.
Researchers found that nitrite therapy reduces cell death and preserves organ function in mouse models of I/R injury. Nitrite may serve as a therapeutic treatment for I/R disease, particularly in preventing organ dysfunction following surgery or transplantation.
A Umeå research team has made a breakthrough in understanding how obesity causes diabetes, fatty liver, and blood-fat disturbances. The study found that mice lacking a specific receptor, GPR40, are protected from these complications when fed a calorie-rich diet.
A new mouse model has shown reduced blood glucose levels and lower serum insulin, indicating improved glucose tolerance in the liver. The study found that Gab1 acts as a negative regulator on insulin signal strength in the liver, suggesting potential therapeutic targets for type 2 diabetes.
Researchers at Wake Forest University School of Medicine have found that the liver is the main source of high-density lipoprotein (HDL), or 'good' cholesterol. This discovery could lead to new treatments for raising HDL levels, particularly in individuals with less severe cholesterol disorders.
Researchers have discovered a new role for NKT cells in the liver, which crawl along vessel walls to detect foreign molecules and trigger an immune response. This finding offers a potential new approach to treating hepatitis by manipulating the NKT cell's behavior and reducing inflammation.
Scientists discover NKT cells primarily patrol liver blood vessels, showcasing agility and rapid movement. The study reveals surprises about NKT cell behavior, including their ability to survive without the CXCR6 gene.
The NASH Clinical Research Network is launching two trials to treat nonalcoholic steatohepatitis (NASH), a leading cause of cirrhosis in the US. The trials will test the efficacy of insulin-sensitizing agents and antioxidants, such as vitamin E, in slowing or reversing disease progression.
A systematic review found that Hepatitis C significantly impacts quality of life, affecting physical and social function, general health and vitality. Researchers established a minimally clinically important difference in vitality scale to monitor patient outcomes.
Research suggests statins can cause asymptomatic elevation of aminotransferases, especially at higher doses, but rare reports of significant liver injury exist; monitoring liver values is recommended for patients on statins, particularly those with known liver conditions.
Scientists have identified two populations of immune cells in the liver that can cause scarring and break it down. This discovery may lead to future treatments for liver damage and cirrhosis, a condition that affects more women in the UK than cervical cancer.
A study of liver transplant patients found that older donors, longer cold ischemia times, and urgent recipient status are significant risk factors for shortened graft survival. The results suggest a new model to predict post-transplant survival, potentially improving organ allocation decisions.
A study of 54 patients with ALD who underwent liver transplants found that those who resumed alcohol consumption had significantly lower 10-year survival rates compared to abstinent patients. Higher mortality rates among relapse group were attributed to increased risk of cancers and cardiovascular events.
A study of liver transplant patients with hepatitis C found that donor age does not impact long-term survival rates. Instead, maintenance azathioprine was associated with improved overall and 3-month survival rates, suggesting a complex relationship between immunosuppression and disease progression.
Researchers have developed a gene therapy that completely cures Crigler-Najjar syndrome, a liver disease, in rats using a specially designed adenovirus. The treatment has no long-term effect and poses no risk of cancer, making it a promising approach for treating other diseases with similar genetic deficiencies.
Researchers identify new therapeutic targets for immune-mediated liver diseases and explore the role of IL-6 in protecting liver cells. Osteopontin is also found to play a central role in amplifying rheumatoid arthritis, suggesting potential new treatments for this inflammatory condition.